首页 | 本学科首页   官方微博 | 高级检索  
     


Rituximab-induced Ileocolitis in a Patient with Gastric MALToma: A Case Report and Literature Review
Authors:Yoshikazu Tsuzuki  Rie Shiomi  Keigo Ashitani  Kazuya Miyaguchi  Atsushi Osaki  Hideki Ohgo  Rei Kim  Atsushi Sasaki  Taketo Yamada  Yoshitaka Miyakawa  Hidetomo Nakamoto  Hiroyuki Imaeda
Affiliation:1.Department of Gastroenterology, Saitama Medical University, Japan; 2.Department of General Internal Medicine, Saitama Medical University, Japan; 3.Department of Pathology, Saitama Medical University, Japan
Abstract:Rituximab (RTX) is effective for treating cancer, but reports of RTX-associated enterocolitis are limited. We herein report the case of a 65-year-old man who developed RTX-induced ileocolitis. He was diagnosed with gastric mucosa-associated lymphoid tissue lymphoma (MALToma) and treated with RTX. He complained of bloody diarrhea after RTX. Mucosal inflammation on colonoscopy indicated RTX-induced ileocolitis. He was treated with corticosteroids, and his symptoms improved. We reviewed the RTX-associated gastrointestinal adverse events and classified the features into ulcerative colitis, Crohn''s disease, microscopic colitis, and ileocolitis. To our knowledge, this is the first case of a Japanese patient who developed RTX-induced ileocolitis.
Keywords:rituximab   ileocolitis   MALToma   B cells   T cells   inflammatory bowel disease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号